Neal Koller

Chairman of the Board of Directors and CEO at Alphyn Biologics, Inc.

Role
Chairman of the Board of Directors and CEO at Alphyn Biologics, Inc
Location
Annapolis, MD, US
LinkedIn followers
500 followers

About Neal Koller

Global top executive in life sciences with highly successful track-record of building, running and growing both small entrepreneurial and large complex global companies. Recognized as a strategic thinker, innovator, orchestrator of new ideas and deliverer of global results. Excellent communicator, team builder, motivator, and leader - up, down and across complex organizations. Skilled at navigating product regulatory approvals, facility build-outs, operational effectiveness and regulatory compliance. Proven strengths in developing products, growing revenues and profits and creating marketplace footprints across US and International markets. Capital raising, recruiting and working with investors and Boards, a strength. Impeccable integrity and a highly trusted leader.

Experience

  1. Chairman of the Board of Directors and CEO

    Alphyn Biologics, Inc

    Mar 2019 — Present

    Alphyn Biologics, Inc, is clinical-stage life science company developing first-in-class Multi-Target Therapeutics™ initially for severe and prevalent skin diseases based on its AB-101 platform. The Company\'s lead drug candidate, AB-101a, is being developed as a topical treatment for atopic dermatitis (AD), the most common form of eczema. Alphyn’s goal is for AB-101a to be the 1st therapeutic to attack the immune component, and uniquely, the bacterial component of AD, and have a safety and side effect profile that can establish it as the 1st long-term, continuous use drug for AD sufferers. A two-part Phase 2a clinical trial program in AD is underway for children age 2 through adult. The 1st clinical trial is complete meeting all primary endpoints and the 2nd clinical trial is near completion.Alphyn\'s AB-101 platform has multiple bioactive compounds and therefore multiple mechanisms of action to support a robust pipeline of new therapeutics with potential safety, efficacy and regulatory marketing authorization advantages.

Education

  • University of Michigan

    Advanced Management Series, Strategic Product Planning

  • Washington University in St. Louis

    Executive MBA Series, Economics

  • University of Richmond

    BS, Biology

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Neal Koller — Chairman of the Board of Directors and CEO at Alphyn Biologics, Inc in Annapolis, MD, US | Unifers